当前位置: 首页 > 期刊 > 《中国保健营养》 > 2014年第3期 > 正文
编号:12707142
结肠癌患者血清己糖激酶活性变化及其临床意义(2)
http://www.100md.com 2014年2月1日 张晓林 刘娜 翁闪凡
第1页

    参见附件。

     [4] Warburg O.On respiratory impairment in cancer cells[J].Science,1956,124(3215):269-270.

    [5] Marin HA,Rodriguez ES,Gonzalez PA,et al.Determining and understanding the control of glycolysis in fast-growth tumor cells.Flux control by an overexpressed but strongly product-inhibited hexokinase[J].FEBS J,2006,273:1975-1988.

    [6] Wolf A,Agnihotri S,Micallef J,etal.Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.J Exp Med,2011,208(2):313-326.

    [7] Dhup S,Dadhich RK,Porporato PE,et al.Multiple biological activities of lactic acid in cancer:influences on tumor growth,angiogenesis and metastasis[J].Curr Pharm Des,2012,18(10):

    1319-30.

    [8] Yeshowardhana,Singh VS.Significance of serum phosophohexose isomerase,hexokinase and aldolase in carcinoma ovary[J].Indian J Physiol Pharmacol,1985,29(1):51-54.

    [9] Upadhyay M,Samal J,Kandpal M,et al.The Warburg effect:Insights from the past decade[J].Phar-macol Ther,2013,137(3):318-330.

您现在查看是摘要介绍页,详见PDF附件